Thursday, August 27, 2020 3:02:49 PM
By Riley Griffin
August 26, 2020, 5:00 PM EDT
https://www.bloomberg.com/news/articles/2020-08-26/operation-warp-speed-hedges-bets-on-different-vaccine-platforms?utm_source=url_link
The White House has secured eight experimental coronavirus vaccines through its “Operation Warp Speed” effort, seeking to hedge its bets on different technologies, according to a top adviser to the program.
Moncef Slaoui, the operation’s chief adviser, and Matthew Hepburn, a Department of Defense official, outlined the federal criteria for selecting and securing vaccine candidates in an essay in the New England Journal of Medicine on Wednesday.
Slaoui and Hepburn wrote that that each candidate selected for the ‘Warp Speed’ portfolio must employ 1 of 4 types of vaccine platform technologies believed by the U.S. to likely yield a safe and effective shot. That includes newer technologies like so-called messenger RNA, as well as older ones using a weakened form of a pathogen to induce an immune response without causing disease.
So far, the government has announced deals for supplying six Covid-19 vaccines candidates. Those shots are being developed by Johnson & Johnson, Moderna Inc., Pfizer Inc. in partnership with BioNTech SE, the University of Oxford in collaboration with AstraZeneca Plc, Sanofi with GlaxoSmithKline Plc, and Novavax Inc.
The final two unnamed candidates will enter trials soon, Slaoui and Hepburn said.
Operations Warp Speed’s other requirements for inclusion in its portfolio are:
1.) robust pre-clinical or early stage vaccine data
2.) the ability to enter large, late-stage trials in the summer or fall
3.) the ability to manufacture at scale, with more than 100 million doses ready by mid-2021
Bloomberg reported in June that Merck & Co. had also been tapped for the operation’s portfolio, though no formal announcement has been made. One of Merck’s two vaccine candidates -- based on a measles shot used in Europe -- enters the clinic this month. A spokeswoman for Merck declined to comment on whether the company had reached an agreement with the U.S.
Operation Warp Speed is an effort that brings together the Department of Health and Human Services, the Biomedical Advance Research and Development Authority and the Department of Defense, as well as other agencies, to expedite the development, manufacturing and distribution of coronavirus inoculations and treatments.
On Wednesday, Slaoui and Hepburn reiterated that the government wants to have tens of millions of doses of a Covid-19 vaccine approved or authorized for use by the end of 2020, and as many as 300 million doses available and deployed by mid-2021.
Slaoui and Hepburn said the U.S. will ensure that all selected vaccines enroll 30,000 to 50,000 participants in late-stage trials, and that trial endpoints are “harmonized to permit appropriate comparisons.”
The U.S. is working to ensure that “the most vulnerable and at-risk persons will receive vaccine doses once they are ready,” Slaoui and Hepburn said in the New England Journal of Medicine report. But that will also depend on the relative performance of each vaccine in various populations.
Recent IBIO News
- iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases • GlobeNewswire Inc. • 03/27/2024 11:00:00 AM
- iBio Announces $15.0 Million Private Placement • GlobeNewswire Inc. • 03/26/2024 11:35:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 12:59:30 PM
- iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka • GlobeNewswire Inc. • 02/26/2024 12:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:55:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:36:09 PM
- iBio Announces Participation in 23rd Annual PepTalk Conference • GlobeNewswire Inc. • 01/16/2024 01:15:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/10/2024 06:24:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 09:30:59 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/04/2024 01:00:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 12:44:38 PM
- iBio Amends and Extends Maturity of Credit Agreement • GlobeNewswire Inc. • 12/26/2023 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 09:17:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 02:13:08 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/06/2023 01:59:51 PM
- iBio, Inc. Announces Pricing of $4.5 Million Public Offering • GlobeNewswire Inc. • 12/05/2023 01:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/05/2023 05:15:18 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/30/2023 01:55:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 01:36:43 PM
- iBio Announces Reverse Stock Split • GlobeNewswire Inc. • 11/27/2023 10:20:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/03/2023 08:01:14 PM
- iBio Further Expands Tech Stack with ShieldTx™; Enhances Immuno-Oncology Development Pipeline with Conditionally Activated MUC16xCD3 Bispecific • GlobeNewswire Inc. • 11/01/2023 12:24:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 10/27/2023 08:29:45 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/26/2023 12:20:58 PM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM